RVL Pharmaceuticals PLC (RVLPQ)
0.00
USD |
OTCM |
May 31, 16:00
RVL Pharmaceuticals Cash from Operations (Quarterly): -12.06M for June 30, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -12.06M |
| March 31, 2023 | -5.818M |
| December 31, 2022 | -16.43M |
| September 30, 2022 | -10.10M |
| June 30, 2022 | 1.996M |
| March 31, 2022 | -13.28M |
| December 31, 2021 | -24.40M |
| September 30, 2021 | -15.93M |
| June 30, 2021 | -2.922M |
| March 31, 2021 | -11.49M |
| December 31, 2020 | -8.252M |
| Date | Value |
|---|---|
| September 30, 2020 | 9.541M |
| June 30, 2020 | 16.36M |
| March 31, 2020 | -0.064M |
| December 31, 2019 | 0.675M |
| September 30, 2019 | 37.05M |
| June 30, 2019 | 1.968M |
| March 31, 2019 | -6.127M |
| December 31, 2018 | 30.38M |
| September 30, 2018 | 7.228M |
| June 30, 2018 | -7.156M |
| March 31, 2018 | 7.102M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-24.40M
Minimum
Dec 2021
37.05M
Maximum
Sep 2019
-3.126M
Average
-5.818M
Median
Mar 2023
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -3.654M |
| Theriva Biologics Inc | -4.881M |
| Oragenics Inc | -3.064M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.959M |
| Cash from Financing (Quarterly) | -0.46M |
| Free Cash Flow | -47.48M |
| Free Cash Flow Per Share (Quarterly) | -0.1319 |
| Free Cash Flow to Equity (Quarterly) | -13.67M |
| Free Cash Flow to Firm (Quarterly) | -9.966M |